Proficio Capital Partners LLC Makes New Investment in STERIS plc (NYSE:STE)

Proficio Capital Partners LLC bought a new stake in STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 48,136 shares of the medical equipment provider's stock, valued at approximately $9,895,000.

A number of other institutional investors have also recently made changes to their positions in the company. Ashton Thomas Securities LLC acquired a new stake in STERIS in the 3rd quarter valued at about $25,000. Human Investing LLC purchased a new stake in shares of STERIS in the fourth quarter valued at approximately $31,000. Central Pacific Bank Trust Division increased its holdings in shares of STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares during the last quarter. Manchester Capital Management LLC lifted its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after buying an additional 137 shares in the last quarter. Finally, Quarry LP acquired a new position in STERIS during the third quarter worth $67,000. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Trading Up 0.9 %

STE stock traded up $1.98 during mid-day trading on Thursday, hitting $229.41. 387,827 shares of the company were exchanged, compared to its average volume of 486,906. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The firm has a market capitalization of $22.54 billion, a P/E ratio of 48.66 and a beta of 0.84. The business has a fifty day simple moving average of $215.99 and a 200-day simple moving average of $222.79. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS's dividend payout ratio (DPR) is 48.41%.

Analysts Set New Price Targets

STE has been the topic of several analyst reports. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Friday, November 8th. Stephens reiterated an "overweight" rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, JMP Securities restated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.